Posters and Publications
Publications
 |
ANG1005, an Angiopep-2/paclitaxel conjugate:
The first clinical trial in patients with advanced cancer and brain metastases – preliminary safety and tolerability data // Presented at the EORTC-NCI-AACR Annual Meeting 2008, Geneva, Switzerland, October 22/23, 2008 |
|
ANG1005: Preliminary clinical safety and tolerability in patients with recurrent malignant glioma // Presented at the EORTC-NCI-AACR Annual Meeting 2008, Geneva, Switzerland, October 22/23, 2008 |
|
ANG1005, Paclitaxel conjugated to the Angiopep brain transport vector
for the treatment of brain cancer: preclinical studies // Presented at the EORTC-NCI-AACR Annual Meeting 2008, Geneva, Switzerland, October 22/23, 2008 |
Posters
|
ANG1005, the first clinical trial in patients with malignant glioma:
Preliminary safety and tolerability data // Society for Neuro-Oncology Annual Meeting, Las Vegas, Nevada, USA, 21/22-Nov-2008 |
|
Angiopep-2/paclitaxel conjugate, ANG1005:
A potential treatment option for patients with metastatic brain cancer// Society for Neuro-Oncology Annual Meeting, Las Vegas, Nevada, USA, 21/22-Nov-2008 |
|
ET-09 : A new drug, ANG1005, a conjugate of Paclitaxel and Angiopep peptide vector able to cross the
Blood-Brain Barrier for the treatment of brain cancers. // Society for Neuro-Oncology Annual Meeting, Las Vegas, Nevada, USA, 21/22-Nov-2008 |
|
655.15 / DD18 : Angiopeps: a new peptide family for the transport of small and large molecules
to the brain // Presented at Neuroscience 2008, Washington DC, USA, 18-Nov-2008 |
This page contains only recent documents.
To access previous publications,
click here.
